Revolution Medicines (RVMD) Change in Account Payables (2019 - 2026)

Revolution Medicines' Change in Account Payables history runs 8 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• On a quarterly basis, Change in Account Payables rose 303.83% year-over-year to $16.9 million in Q1 2026; TTM through Mar 2026 was $34.7 million, a 143.67% increase from a year earlier, with the FY2025 full-year figure at $9.5 million, up 247.49% from the prior year.
• Change in Account Payables advanced to $16.9 million in Q1 2026 per RVMD's latest filing, from -$10.5 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $29.4 million in Q4 2024 and bottomed at -$29.0 million in Q1 2024.
• The 5-year median for Change in Account Payables is -$492000.0 (2022), against an average of $3.5 million.
• Across the five-year window, Change in Account Payables soared 5317.46% in 2022 and plunged 2658.1% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at -$1.5 million in 2022, then soared by 1712.81% to $24.3 million in 2023, then grew by 20.81% to $29.4 million in 2024, then sank by 135.76% to -$10.5 million in 2025, then jumped by 260.53% to $16.9 million in 2026.
• Per Business Quant, the three latest RVMD Change in Account Payables figures stand at $16.9 million (Q1 2026), -$10.5 million (Q4 2025), and $19.5 million (Q3 2025).